Actively Recruiting
ICOPE INTENSE-K Pilot Study
Led by University Hospital, Toulouse · Updated on 2025-07-23
40
Participants Needed
1
Research Sites
25 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
ICOPE could constitute the reference model of care for healthy aging. More specifically, our hypothesis is that the intervention implemented in ICOPE may directly or indirectly prevent immuno-senescence, the loss of mobility and the cognitive decline. In future Geroscience clinical trials, ICOPE-Intense could become a benchmark to reduce the rate of aging with a strong non-pharmacological intervention and state a reference intervention to compare with new gerotherapeutic drugs.
CONDITIONS
Official Title
ICOPE INTENSE-K Pilot Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Independent-living with ability to perform at least 5 of 6 activities of daily living
- Men and women aged 65 to 85 years
- Mobility impairment defined as taking more than 12 seconds to perform 5 chair rises
- Sedentary lifestyle, spending six or more hours per day sitting or lying down
- Positive screening for cognitive impairment with Mini-Mental State Examination score between 25 and 28
- Body mass index of 25 kg/m2 or higher
You will not qualify if you...
- Unintentional weight loss of 10% or more in the past 6 months
- Diagnosis of dementia
- Life-threatening illness with life expectancy less than 1 year as judged by the doctor
- Severe heart disease including advanced heart failure, significant aortic stenosis, history of cardiac arrest, use of a cardiac defibrillator, uncontrolled angina, or other contraindications to physical activity
- Comorbid conditions impairing ability to participate, such as renal failure on hemodialysis or severe psychiatric disorders (depression does not exclude participation)
- Unable to attend sessions three times per week for 60 days
- Living in a nursing home
- Under legal protection measures such as guardianship or curatorship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cité de la santé - Hopital La Grave
Toulouse, France, 31059
Actively Recruiting
Research Team
Y
Yves ROLLAND
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here